questionsmedicales.fr
Maladies de l'appareil digestif
Tumeurs de l'appareil digestif
Tumeurs des voies biliaires
Tumeurs de la vésicule biliaire
Tumeurs de la vésicule biliaire : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Tumeurs de la vésicule biliaire : Questions médicales les plus fréquentes",
"headline": "Tumeurs de la vésicule biliaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Tumeurs de la vésicule biliaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-04",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Tumeurs de la vésicule biliaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Tumeurs des voies biliaires",
"url": "https://questionsmedicales.fr/mesh/D001661",
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs des voies biliaires",
"code": {
"@type": "MedicalCode",
"code": "D001661",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.301.120"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Tumeurs de la vésicule biliaire",
"alternateName": "Gallbladder Neoplasms",
"code": {
"@type": "MedicalCode",
"code": "D005706",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yasuni Nakanuma",
"url": "https://questionsmedicales.fr/author/Yasuni%20Nakanuma",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan; Department of Diagnostic Pathology, Fukui Prefecture Hospital, Fukui, Japan. Electronic address: nakanumayasu@gmail.com."
}
},
{
"@type": "Person",
"name": "Takashi Sugino",
"url": "https://questionsmedicales.fr/author/Takashi%20Sugino",
"affiliation": {
"@type": "Organization",
"name": "Department of Diagnostic Pathology, Shizuoka Cancer Center, Shizuoka, Japan."
}
},
{
"@type": "Person",
"name": "Takuro Terada",
"url": "https://questionsmedicales.fr/author/Takuro%20Terada",
"affiliation": {
"@type": "Organization",
"name": "Department of Digestive Surgery, Fukui Prefecture Hospital, Fukui, Japan."
}
},
{
"@type": "Person",
"name": "Yasunori Sato",
"url": "https://questionsmedicales.fr/author/Yasunori%20Sato",
"affiliation": {
"@type": "Organization",
"name": "Department of Human Pathology, Kanazawa University Graduate School of Medicine, Kanazawa, Japan."
}
},
{
"@type": "Person",
"name": "Yoshikatsu Nomura",
"url": "https://questionsmedicales.fr/author/Yoshikatsu%20Nomura",
"affiliation": {
"@type": "Organization",
"name": "Department of Internal Medicine, Fukui Prefecture Hospital, Fukui, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A rapid fluorescent aptasensor for point-of-care detection of C-reactive protein.",
"datePublished": "2022-06-04",
"url": "https://questionsmedicales.fr/article/35714415",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.talanta.2022.123661"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein and 10-year cardiovascular risk in rheumatoid arthritis.",
"datePublished": "2022-07-09",
"url": "https://questionsmedicales.fr/article/35821191",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ejim.2022.07.001"
}
},
{
"@type": "ScholarlyArticle",
"name": "C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.",
"datePublished": "2022-06-24",
"url": "https://questionsmedicales.fr/article/35766701",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1806-9282.20220236"
}
},
{
"@type": "ScholarlyArticle",
"name": "Life's Essential 8 is inversely associated with high-sensitivity C-reactive protein.",
"datePublished": "2024-07-01",
"url": "https://questionsmedicales.fr/article/38951604",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-65977-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Investigation of Peptides for Molecular Recognition of C-Reactive Protein-Theoretical and Experimental Studies.",
"datePublished": "2023-09-11",
"url": "https://questionsmedicales.fr/article/37695838",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acs.analchem.3c03127"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004067"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs des voies biliaires",
"item": "https://questionsmedicales.fr/mesh/D001661"
},
{
"@type": "ListItem",
"position": 5,
"name": "Tumeurs de la vésicule biliaire",
"item": "https://questionsmedicales.fr/mesh/D005706"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Tumeurs de la vésicule biliaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Tumeurs de la vésicule biliaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Tumeurs de la vésicule biliaire",
"description": "Comment diagnostique-t-on une tumeur de la vésicule biliaire ?\nQuels tests d'imagerie sont utilisés ?\nLes marqueurs tumoraux sont-ils utiles ?\nQuand faut-il envisager une cholangiographie ?\nQuels symptômes peuvent alerter sur une tumeur ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Tumeurs de la vésicule biliaire",
"description": "Quels sont les symptômes courants des tumeurs ?\nLa perte de poids est-elle un symptôme ?\nLes démangeaisons peuvent-elles survenir ?\nLes douleurs irradiantes sont-elles fréquentes ?\nPeut-on avoir des symptômes sans tumeur visible ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Tumeurs de la vésicule biliaire",
"description": "Peut-on prévenir les tumeurs de la vésicule biliaire ?\nLe contrôle du poids est-il important ?\nUne alimentation équilibrée aide-t-elle ?\nLe tabagisme influence-t-il le risque ?\nLes infections chroniques jouent-elles un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Tumeurs de la vésicule biliaire",
"description": "Quel est le traitement principal des tumeurs ?\nLa chimiothérapie est-elle utilisée ?\nQuand la radiothérapie est-elle indiquée ?\nY a-t-il des traitements ciblés disponibles ?\nQuels soins palliatifs sont possibles ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Tumeurs de la vésicule biliaire",
"description": "Quelles complications peuvent survenir ?\nLes métastases sont-elles possibles ?\nPeut-on avoir des infections secondaires ?\nLes douleurs chroniques sont-elles fréquentes ?\nY a-t-il un risque de récidive ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Tumeurs de la vésicule biliaire",
"description": "Quels sont les principaux facteurs de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'obésité est-elle un facteur de risque ?\nLes maladies inflammatoires augmentent-elles le risque ?\nLe sexe influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D005706?mesh_terms=C-Reactive+Protein&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une tumeur de la vésicule biliaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par échographie, scanner et parfois par biopsie."
}
},
{
"@type": "Question",
"name": "Quels tests d'imagerie sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'échographie et le scanner abdominal sont les principaux tests d'imagerie."
}
},
{
"@type": "Question",
"name": "Les marqueurs tumoraux sont-ils utiles ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des marqueurs comme le CA 19-9 peuvent aider au diagnostic."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une cholangiographie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une cholangiographie est envisagée si une obstruction biliaire est suspectée."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent alerter sur une tumeur ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, une jaunisse ou des nausées peuvent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des tumeurs ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent douleurs abdominales, nausées, et jaunisse."
}
},
{
"@type": "Question",
"name": "La perte de poids est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une perte de poids inexpliquée peut être un symptôme."
}
},
{
"@type": "Question",
"name": "Les démangeaisons peuvent-elles survenir ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons peuvent être liées à une obstruction biliaire."
}
},
{
"@type": "Question",
"name": "Les douleurs irradiantes sont-elles fréquentes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs peuvent irradier vers l'épaule droite ou le dos."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans tumeur visible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes peuvent exister sans tumeur détectable à l'imagerie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les tumeurs de la vésicule biliaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un mode de vie sain aide."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids est-il important ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé peut réduire le risque de tumeurs."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée aide-t-elle ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en fruits et légumes peut diminuer le risque."
}
},
{
"@type": "Question",
"name": "Le tabagisme influence-t-il le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme est un facteur de risque pour plusieurs cancers, y compris ceux-ci."
}
},
{
"@type": "Question",
"name": "Les infections chroniques jouent-elles un rôle ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines infections chroniques peuvent augmenter le risque de tumeurs."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal des tumeurs ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est le traitement principal, souvent une cholécystectomie."
}
},
{
"@type": "Question",
"name": "La chimiothérapie est-elle utilisée ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chimiothérapie peut être utilisée pour les tumeurs malignes avancées."
}
},
{
"@type": "Question",
"name": "Quand la radiothérapie est-elle indiquée ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La radiothérapie est indiquée pour soulager les symptômes ou en cas de récidive."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements ciblés disponibles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements ciblés sont en développement, mais leur utilisation est limitée."
}
},
{
"@type": "Question",
"name": "Quels soins palliatifs sont possibles ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins palliatifs visent à soulager la douleur et améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la propagation de la tumeur et l'obstruction biliaire."
}
},
{
"@type": "Question",
"name": "Les métastases sont-elles possibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tumeurs de la vésicule biliaire peuvent métastaser à d'autres organes."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des infections secondaires ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des infections secondaires peuvent survenir en raison d'une obstruction."
}
},
{
"@type": "Question",
"name": "Les douleurs chroniques sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs chroniques peuvent persister après traitement."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque de récidive ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de récidive est présent, surtout pour les tumeurs malignes."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents de calculs biliaires."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'obésité est-elle un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est associée à un risque accru de tumeurs de la vésicule biliaire."
}
},
{
"@type": "Question",
"name": "Les maladies inflammatoires augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la cholécystite chronique peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes sont plus susceptibles de développer des tumeurs de la vésicule biliaire."
}
}
]
}
]
}
In this paper, we report on a novel fluorescent aptasensor based on aptamers modified by both nitrogen-doped graphene quantum dots (N-GQDs) and gold nanoparticles (AuNPs) for the detection of C-reacti...
To evaluate the association between C-reactive protein (CRP) and 10-year risk of cardiovascular (CV) events using the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis (ERS-RA), b...
ERS-RA was calculated in 1,251 "Cardiovascular Obesity and Rheumatic Disease Study (CORDIS)" database patients [(age 60.4(9.3) years; 78% female; disease duration, 11.6(8) years; CDAI, 9(9); CRP, 6.8(...
The mean (SD) 10-year risk of CV events was 12.9% (10). After adjusting for the use of DMARDs and biologics, CRP concentrations were significantly associated with 10-year risk of CV events (coefficien...
In a large cohort of RA patients without previous cardiovascular events, a 20 mg/L increase in CRP concentrations was associated with a 1% increase in 10-year risk of CV events. This suggests that act...
Chronic hepatitis C (CHC) is one of the most important health problems affecting the significant rate of world population and it may lead to cirrhosis and hepatocellular carcinoma. C-reactive protein ...
Patients with CHC infection who visited outpatient and inpatient internal medicine clinics of our institution between January 2021 and December 2021 were enrolled to this retrospective study. CLR of t...
Median CLR of CHC and control subjects was 2.61 (5.13%) and 0.31 (0.37%), respectively. CLR of the CHC group was significantly increased compared to the CLR of the controls (p<0.001). There was a sign...
Increased CLR in patients with CHC may be an alarming finding of liver fibrosis, as CLR is associated with both CHC and hepatic fibrosis....
Life's Essential 8 (LE8) is a score that includes modifiable risk factors for cardiovascular disease. Four health behaviors (diet, physical activity, nicotine exposure and sleep health) and four healt...
We investigate the interactions between C-reactive protein (CRP) and new CRP-binding peptide materials using experimental (biological and physicochemical) methods with the support of theoretical simul...
To assess whether low-grade inflammation, measured by serum high-sensitivity C-reactive protein (hsCRP) levels, is associated with...
A retrospective study....
University-affiliated IVF center....
In the present study, 875 women of normal weight who underwent their first fresh embryo transfer (ET) cycles for IVF treatment were divided into three groups according to serum concentrations of hsCRP...
Serum from women undergoing IVF was collected on days 2-4 of a spontaneous menstrual cycle prior to the commencement of ovarian stimulation....
The IVF outcomes included implantation, biochemical pregnancy, clinical pregnancy, miscarriage and live birth rates....
The women were divided into three groups according to the baseline serum levels of hsCRP as follows: low hsCRP (<1 mg/L; n=517), medium hsCRP (1-3 mg/L; n= 270), high hsCRP (>3 mg/L; n=88). The matern...
Among women of normal weight undergoing their first IVF treatment, it was found that low-grade inflammation was associated with reduced clinical pregnancy and live birth rates following fresh ET cycle...
Interest in using bedside C-reactive protein (CRP) and ferritin levels to identify patients with hyperinflammatory sepsis who might benefit from anti-inflammatory therapies has piqued with the COVID-1...
A prospective, observational cohort study....
Children with sepsis and organ failure in nine pediatric intensive care units in the United States....
Two hundred and fifty-five children were enrolled. Five distinct clinical multi-trajectory groups were identified. Plasma CRP (mg/dL), ferritin (ng/mL), and 31 cytokine levels were measured at two tim...
Group 1 had normal CRP and ferritin levels ( n = 8; 0% mortality); Group 2 had high CRP levels that became normal, with normal ferritin levels throughout ( n = 80; 5% mortality); Group 3 had high ferr...
Bedside CRP and ferritin levels can be used together to distinguish groups of children with sepsis who have different systemic inflammation cytokine responses and mortality risks. These data suggest f...
Social relationships are an important driver of health, and inflammation has been proposed as a key neurobiological mechanism to explain this effect. Behavioral researchers have focused on social rela...
Stroke is the third most common cause of death in the world. Plasma homocysteine is an emerging risk factor for stroke. Also, previous studies have shown that serum levels of C-reactive protein (CRP) ...
Methamphetamine use disorder causes significant crises, which have individual, familial, and social consequences. Identifying inflammatory biomarkers for methamphetamine use disorder may be useful for...
The sample comprised 139 treatment-seeking participants who met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria for methamphetamine use disorder and 139 socio...
CAR (...
CAR may be a potential inflammatory biomarker for patients with methamphetamine use disorder. CAR as a relatively easier-to-measure biomarker could be beneficial to follow the inflammatory status and ...